Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Lidocaine for Propofol Sparing in Gastroscopy
NCT05944887Completed
- Sponsor
- Erasmus Hospital
- Start
- Jul 2023
- Primary completion
- Aug 2023
- Modality
- Device-based Delivery, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine (2 arms), sponsored by Erasmus Hospital. Primary endpoints: Total propofol dose and Propofol in site effect concentration. Started Jul 2023; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NCT05944887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05944887.